Mouse Anti-Migis-α Recombinant Antibody (clone 29C11) (CAT#: FAMAB-0227CQ)

Recombinant Mouse Antibody clone 29C11, which is specific to Migis-α. mAb 29C11, specific to a segment towards the N-terminus of the 26 amino acid long migis-α. The mAbs bound strongly to synthetic peptides of migis-α and to various recombinant proteins containing migis-α as revealed by ELISA.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
ELISA

Figure 1 A graph which depicts an ELISA showing the reactivity of an anti-IgA.

Figure 1 A graph which depicts an ELISA showing the reactivity of an anti-IgA.

Fc mAb (3C10) and two anti-migis-α mAbs (8G7 and 29C11) with human IgA and constructs, which contain various human membrane-bound α chain, or other components.

ELISA

Figure 2 Epitope mapping of anti-migis-α mAbs in ELISA.

Figure 2 Epitope mapping of anti-migis-α mAbs in ELISA.

A shows binding reactivity of anti-migis-α mAbs with different parts of migis-αL. B shows binding reactivity of anti-migis-α mAbs with short peptides of the N-terminal part of migis-αL.

ELISA

Figure 3 Determination of the relative affinity of 8G7 and 29C11 in binding to ma in ELISA.

Figure 3 Determination of the relative affinity of 8G7 and 29C11 in binding to ma in ELISA.

A shows binding strength of 8G7 and 29C11 against mα1.FcL-456S-LZ proteins. B. shows relative ability of 8G7 and 29C11 in competing with 200 nM biotin-conjugated 29C11 in binding to FcL-456S-LZ protein.

FC

Figure 4 Staining profiles of anti-migis-α mAbs on DAKIKI cells and mα1.Fc-expressing Ramos transfectomas.

Figure 4 Staining profiles of anti-migis-α mAbs on DAKIKI cells and mα1.Fc-expressing Ramos transfectomas.

The gray profiles are negative control mAbs of the same IgG isotypes.

FuncS

Figure 5 The reactivity of anti-migis-α mAbs toward DAKIKI cells with or without MβCD treatments.

Figure 5 The reactivity of anti-migis-α mAbs toward DAKIKI cells with or without MβCD treatments.

FuncS

Figure 6 Results indicating that 3C10 and 8G7 can induce apoptosis in two mα1.Fc-expressing Ramos transfectomas, whereas 29C11 fails to do so.

Figure 6 Results indicating that 3C10 and 8G7 can induce apoptosis in two mα1.Fc-expressing Ramos transfectomas, whereas 29C11 fails to do so.

ELISA

Figure 7 Recombinant proteins used in this study and the reactivity of anti-migis-α mAbs with these proteins as detected by ELISA

Figure 7 Recombinant proteins used in this study and the reactivity of anti-migis-α mAbs with these proteins as detected by ELISA

Reactivity of anti-migis-α mAbs with Proteins I, II, and III as detected by ELISA. The mAbs 7C3, 9F5, and 29C11 were developed in the present study. 3C10, an anti-IgA1.Fc mAb; 4B12 (IgG1κ) and a20 (IgG2aκ), both specific for "CεmX", a domain located between CH4 and the migis segment of mε, used as isotype controls; mεFcL-LZ, a recombinant protein of mε.

Hung, A. F. H., Chen, J. B., Lu, C. S., Chen, N. Y., Yu, H. M., & Chang, T. W. (2011). Lipid rafts hinder binding of antibodies to the extracellular segment of the membrane-anchor peptide of mIgA. Molecular immunology, 48(15-16), 1975-1982.

ELISA

Figure 8 Competition of mAbs 7C3 and 9F5 with 29C11 for binding to migis-α.

Figure 8 Competition of mAbs 7C3 and 9F5 with 29C11 for binding to migis-α.

Biotin-conjugated 29C11 was mixed with various concentrations of mAbs before the mixtures were placed in microtiter wells coated with mFcL-LZ. Following incubation, HRP-conjugated avidin and its substrate, TMB, were applied for colorimetric measurements.

Hung, A. F. H., Chen, J. B., Lu, C. S., Chen, N. Y., Yu, H. M., & Chang, T. W. (2011). Lipid rafts hinder binding of antibodies to the extracellular segment of the membrane-anchor peptide of mIgA. Molecular immunology, 48(15-16), 1975-1982.

WB

Figure 9 Ability of anti-migisα mAbs to capture mIgA from lysed B cells.

Figure 9 Ability of anti-migisα mAbs to capture mIgA from lysed B cells.

DAKIKI cells and Daudi transfectants lysed in ice-cold detergent-containing buffer were incubated with a mAb and Protein G beads were added to absorb the mAb and its complex. Pulled mixture was then subjected to Western blot analysis. The proteins in the mixture were resolved in polyacrylamide gel electrophoresis (10% SDS), transferred to PVDF membrane, reacted with HRP-conjugated goat anti-human IgA or anti-mouse IgG, and analyzed by chemo-luminescence. (A) Cells lysed in TNE buffer containing 1% Triton X-100; (B) Cells lysed in RIPA buffer; (C) Cells treated with 10 mM MCD and then lysed in TNE buffer containing 1% Triton X-100.

Hung, A. F. H., Chen, J. B., Lu, C. S., Chen, N. Y., Yu, H. M., & Chang, T. W. (2011). Lipid rafts hinder binding of antibodies to the extracellular segment of the membrane-anchor peptide of mIgA. Molecular immunology, 48(15-16), 1975-1982.

ELISA

Figure 10 Effects of mIgA cross-linking on the staining of mIgA-expressing B cells by 29C11.

Figure 10 Effects of mIgA cross-linking on the staining of mIgA-expressing B cells by 29C11.

(A) The binding of mAb 3C10, but not 29C11,to mFcL-LZ is inhibited by goat IgG anti-human IgA (anti-huIgA) as revealed by ELISA. In this assay, non-immunized goat IgG or goat anti-human IgA were incubated with mFcL-LZ, before 3C10 or 29C11 was added. HRP-conjugated goat anti-mouse IgG was used for colorimetric measurements. (B) DAKIKI and Daudi/mFcL cells were incubated with goat IgG or goat anti-human IgA and then stained by 3C10 or 29C11. FITC-conjugated goat F(ab)2 anti-mouse IgG were used for flow cytometric analysis. Histograms–shaded, cells incubated without 3C10 or 29C11; grey lines, cells incubated with goat IgG; black lines, cells incubated with goat IgG anti-human IgA.

Hung, A. F. H., Chen, J. B., Lu, C. S., Chen, N. Y., Yu, H. M., & Chang, T. W. (2011). Lipid rafts hinder binding of antibodies to the extracellular segment of the membrane-anchor peptide of mIgA. Molecular immunology, 48(15-16), 1975-1982.


Specifications

  • Immunogen
  • Migis-peptide-conjugated KLH
  • Host Species
  • Mouse
  • Derivation
  • Mouse
  • Type
  • Mouse IgG1, κ
  • Specificity
  • Human Migis-α
  • Species Reactivity
  • Human
  • Clone
  • 29C11
  • Applications
  • ELISA, FC, WB, FuncS
  • Related Disease
  • IgA lymphoctyes, IgA nephropathy (IgAN)

Product Property

  • Purity
  • >95% as determined by SDS-PAGE and HPLC analysis
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • This antibody has been tested for use in Enzyme-linked Immunosorbent Assay, Flow Cytometry, Western Blot and Functional Assay.

Target

  • Alternative Names
  • migis-α; mIg isotype-specific segment

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 29C11"

See other products for "Migis-α"

Recombinant Antibody

CAT Product Name Application Type
FAMAB-0228CQ Mouse Anti-Migis-α Recombinant Antibody (clone 8G7) ELISA, FC, FuncS Mouse IgG2b, κ
FAMAB-0229CQ Human Anti-Migis-α Recombinant Antibody (clone c8G7) ELISA, FC, ADCC, FuncS Chimeric (mouse/human) IgG1, κ

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for FAMAB-0227CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare